Bioimpedance Analysis in Septic Intensive Care Unit (ICU) Patients
BIOVISION
Does Bio-impedance Analysis Predict Volume Overload States and Clinically Relevant Outcomes in Septic Intensive Care Unit (ICU) Patients With Acute Kidney Injury? A Prospective Observational Study
1 other identifier
observational
55
1 country
1
Brief Summary
Patients with severe infections initially require large amounts of fluid as part of resuscitation. Later on however, problems may arise from excess fluid such as increased time on a ventilator and kidney damage. The amount of fluid a patient has is difficult to assess. One approach is to determine the amount of fluid that is present in a large central vein. This can be done by physical examination of the jugular veins, or by placing a catheter within the vein. Unfortunately this method is unreliable and does not predict the amount of fluid a patient has. Bioimpedance analysis (BIA), is a device that can determine the amount of fluid in the body by measuring the body's electrical properties. It is a quick and painless test that assesses volume. The primary objective of this study is to determine if BIA measurements are associated with patient important outcomes such as time on a ventilator, risk of kidney failure requiring dialysis and death. We will also determine whether BIA is a measure of fluid status in ICU patients. This study will assess feasibility in establishing a multi-centre study assessing if BIA's role in predicting adverse outcomes and thereby prognosis and fluid status. We hypothesize that shorter vector lengths will be associated with hypervolemia and less ventilator free days.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2011
CompletedFirst Submitted
Initial submission to the registry
June 7, 2011
CompletedFirst Posted
Study publicly available on registry
June 23, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2012
CompletedMay 20, 2015
May 1, 2015
1.2 years
June 7, 2011
May 19, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ventilator free days
30 days
Secondary Outcomes (4)
Correlation of BIA vector length with Central venous pressure, edema score, chest x-ray score, and net fluid balance
Time of enrollment (multivariate analysis at day 2 )
Acute Kidney Injury
60 days
Time until ICU discharge
60 days
Mortality
60 days
Interventions
Bioimpedance devices are compact, portable, easy to use, relatively inexpensive and can be used to make repeated non-invasive measurements. Bioimpedance measures the impedance to the flow of an electric current through body fluids and consists of two components, resistance and reactance. Resistance is a measure of electrical current a substance will oppose and is inversely related to tissue fluid content. Reactance is the capacitative component of impedance and indicates energy stored by cell membranes and organelles; due to this property, reactance is associated with tissue cell mass. These raw measures provide a measure of volume as determined by vector length and the RXc graph method.
Eligibility Criteria
All adult patients (\>17 years) admitted to the ICU at SJHH who present with SIRS requiring positive pressure ventilation via endotracheal tube and have a clinical suspicion of infection. Consecutive sampling.
You may qualify if:
- adult patients
- high clinical suspicion for infection
- require positive pressure ventilation
- supraclavicular central line for central venous pressure measurement
You may not qualify if:
- Substitute decision maker unable to consent
- amputation
- pacemaker
- pregnant
- require longterm hemodialysis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- St. Joseph's Healthcare Hamiltonlead
- McMaster Universitycollaborator
Study Sites (1)
St. Joseph's Healthcare Hamilton
Hamilton, Ontario, L8N 4A6, Canada
Related Publications (1)
Rochwerg B, Cheung JH, Ribic CM, Lalji F, Clarke FJ, Gantareddy S, Ranganath N, Walele A, McDonald E, Meade MO, Cook DJ, Wilkieson TT, Clase CM, Margetts PJ, Gangji AS. Assessment of Postresuscitation Volume Status by Bioimpedance Analysis in Patients with Sepsis in the Intensive Care Unit: A Pilot Observational Study. Can Respir J. 2016;2016:8671742. doi: 10.1155/2016/8671742. Epub 2016 Aug 15.
PMID: 27597811DERIVED
Biospecimen
Blood only for chemistry.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Azim Gangji, MD, MSc
St. Joseph's Health Care London
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
June 7, 2011
First Posted
June 23, 2011
Study Start
February 1, 2011
Primary Completion
April 1, 2012
Study Completion
April 1, 2012
Last Updated
May 20, 2015
Record last verified: 2015-05